Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 21 of 21 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/04/19
End: 12/04/21
Due: 12/04/22
Phase: N/A
Priority: Normal
Start: 05/25/21
End: 12/25/25
Due: 12/25/26
Phase: N/A
Priority: Normal
Start: 07/30/22
End: 06/04/23
Due: 06/04/24
Phase: N/A
Priority: Normal
Start: 11/11/23
End: 09/13/25
Due: 09/13/26
Phase: N/A
Priority: Normal
Start: 04/24/23
End: 09/23/25
Due: 09/23/26
Phase: N/A
Priority: Normal
Start: 05/13/24
End: 08/13/25
Due: 08/13/26
Phase: N/A
Priority: Normal
Start: 08/01/23
End: 04/03/24
Due: 04/03/25
Neutrophil-to-lymphocyte Ratio and CA 19.9 as Predictors of Perineural Invasion in Pancreatic Cancer
Phase: N/A
Priority: Normal
Start: 01/01/20
End: 09/30/25
Due: 09/30/26
Phase: N/A
Priority: Normal
Start: 03/20/17
End: 11/30/19
Due: 11/30/20
Phase: N/A
Priority: Normal
Start: 09/03/20
End: 10/31/22
Due: 10/31/23
Phase: N/A
Priority: Normal
Start: 11/15/21
End: 01/16/23
Due: 01/16/24
Phase: N/A
Priority: Normal
Start: 11/01/22
End: 04/21/23
Due: 04/21/24
Phase: N/A
Priority: Normal
Start: 03/22/22
End: 12/01/25
Due: 12/01/26
Phase: N/A
Priority: Normal
Start: 03/07/22
End: 04/27/22
Due: 04/27/23
Phase: N/A
Priority: Normal
Start: 05/01/17
End: 09/30/18
Due: 09/30/19
Phase: N/A
Priority: Normal
Start: 11/11/23
End: 11/01/24
Due: 11/01/25
Phase: N/A
Priority: Normal
Start: 06/01/21
End: 03/08/22
Due: 03/08/23
Phase: N/A
Priority: Normal
Start: 05/28/25
End: 03/20/26
Due: 03/20/27
Phase: N/A
Priority: Normal
Start: 03/28/22
End: 12/27/25
Due: 12/27/26
Phase: N/A
Priority: Normal
Start: 05/01/21
End: 11/18/21
Due: 11/18/22
Phase: N/A
Priority: Normal
Start: 06/01/21
End: 05/08/23
Due: 05/08/24